Rare disease development demands speed, flexibility and scientific partnership. With limited patient populations and critical development timelines, every study matters.

Veloxity Labs specializes in supporting rare disease programs with high-quality LC-MS bioanalysis, validated methods and rapid turnaround. Our team works closely with sponsors to deliver reliable data that supports confident development decisions from discovery through clinical studies.

Why meet with Veloxity?

Let’s discuss how we can support your program with:

• Flexible scientific partnership

• Rare disease expertise

• Rapid study startup and turnaround

• Advanced LC-MS and HRMS capabilities

• Trusted bioanalytical validation

Meeting at Clinical Trials in Rare Diseases?

Connect with Jake Taylor during the conference.